Brazil has started producing 9 million vacancies against Sinovac’s coronavirus and received a total of 3 million more from AstraZeneca

Brazil has increased the production of the 8.6 million of the dose of the vaccine against the COVID-19 of the Chinese laboratory Sinovac, and receive insumos to make others 2.8 million more from AstraZeneca’s formula and Oxford University.

El Instituto Butantan de Sao Paulo, one of the main medical research centers of Brazil, will be the setting of elaborar la vacuna de Sinovac, which is being administered in the country, just like Britain.

“The forecast is what the 8.6 million new doses have been released for Brazilian immunization starting February 23 ”, informed the Governor of Sao Paulo in a communication.

Has the moment he was distributed in Brazil one diez millions of units of Sinovac antidote and others two million from the joint venture between AstraZeneca and the University of Oxford.

According to the dates of the regional secretaries of Salud, about 3.5 million Brazilians received the first dose of some of these vacancies.

In addition, the Butantan Institute has received the nearest 5,600 liters of primary material that will allow it to produce another 8.7 million doses of the “Coronavac”, also of Chinese origin.

Also this Saturday at the Galeao International Airport in Rio de Janeiro, another lot with amounts to the production of 2.8 million doses of AstraZeneca vaccine.

This is the first cargo that goes to Brazil with them Ingredients for the production of British munitions, which will take place at the Oswaldo Cruz Foundation (Fiocruz), another important scientific research center in Brazil.

It’s a moment of we are expectant and we are sure that we will produce this effective and secure vaccine for the National Immunization Program ”, declares the President of Fiocruz, Nísia Trindade.

In addition, the entity is expected to receive antes from the final month. otros of lots with sums that make the creation of more than 15 million dose of the vaccine last March, according to the Ministry of Health in one note.

Brazil has married Mayor Fabina de vacunas de América Latina

En la misma línea, el viernes el Gobierno de Brazil launches this tender for the construction of the mayor of the vacant factories of Latin America, a complex in which it claims to invest 3,400 million in real money (629.6 million in dollars) and which plans to start trading in the second semester of this year.

The Health Biotechnology Industrial Complex in Health (CIBS), which occupies an area of ​​580,000 metro squares of Santa Cruz, barrio en la zona oeste de Rio de janeiro, was a member of the Oswaldo Cruz Foundation (Fiocruz), the mayor of the Latin American Medical Research Center and dependent on the Ministry of Health.

The complex, which Gobierno describes as the mayor’s manufacturing center for Latin American biological products and one of the most modern in the world, tends to capacity to produce 120 million vacancies and biopharmaceuticals per year, with which to quadruple the actual production of Fiocruz.

“This production Rehabilitate Brazil’s self-sufficiency in the field of immunobiology and reduce external dependence, as well as incorporating new products into the medicine card that the country offers free of charge to the population, including vacancies and biopharmacies for chronic, rare, autoimmune and oncologic diseases, ”the Ministry of Health announced in a statement.

The complex “will allow a quick response to emerging sanitation situations such as those generated by the current COVID pandemic“, Agrega la nota.

Agreed with the official dates, Brazil accumulated 231,012 deaths associated with covid-19, with 978 registered in the last 24 hours, and about 9.5 million confirmed cases of illness, at the moment in which a second of the pandemic occurs.

Brazil, with a population of 212 million inhabitants, is the second world peace with mayor number of tens of thousands of coronavirus viruses, after the United States, and the third with more infections, across the EU and India.}

With EFE information

SEGUIR LEYENDO:

The global economy will lose $ 9.2 billion on the unequal share of vacancies against coronavirus

Chile vacations in more than 550,000 people against coronavirus in three days and leads the region

Sinovac vaccine against COVID-19 receives authorization for its commercialization in China